Miyagi Kazuya, Haranaga Shusaku, Higa Futoshi, Tateyama Masao, Fujita Jiro
Department of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases (First Department of Internal Medicine), Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan.
Respir Investig. 2014 Sep;52(5):310-4. doi: 10.1016/j.resinv.2014.06.006. Epub 2014 Jul 25.
In recent clinical practice, high-flow nasal cannula (HFNC) therapy has been used to improve oxygenation in adults with acute respiratory failure (ARF). However, bronchoscopy using HFNC in ARF has not yet been reported. Herein, we describe 5 cases of ARF where bronchoalveolar lavage (BAL) was employed successfully using an HFNC. We were able to discontinue or reduce the HFNC fraction of inspired oxygen (FiO2) 30 min after completion of the bronchoscopy. Only 1 patient needed non-invasive positive pressure ventilation for 16 h after bronchoscopy. The HFNC may be a useful tool for ARF patients who require bronchoscopy.
在最近的临床实践中,高流量鼻导管(HFNC)疗法已被用于改善急性呼吸衰竭(ARF)成人患者的氧合情况。然而,尚未有关于在ARF患者中使用HFNC进行支气管镜检查的报道。在此,我们描述了5例ARF患者,他们成功地使用HFNC进行了支气管肺泡灌洗(BAL)。在支气管镜检查完成后30分钟,我们能够停用或降低HFNC的吸入氧分数(FiO2)。只有1例患者在支气管镜检查后需要无创正压通气16小时。对于需要进行支气管镜检查的ARF患者,HFNC可能是一种有用的工具。